Use of adefovir or tenofovir for inhibiting MMTV-like viruses involved in breast cancer and primary biliary cirrhosis

Details for Australian Patent Application No. 2005209256 (hide)

Owner Gilead Sciences, Inc.

Inventors Douglas, Janet L.; Gibbs, Craig S.; Cihlar, Tomas

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2005209256

PCT Pub. Number WO2005/072748

Priority 60/538,066 21.01.04 US

Filing date 21 January 2005

Wipo publication date 11 August 2005

Acceptance publication date 18 November 2010

International Classifications

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

Event Publications

10 August 2006 PCT application entered the National Phase

  PCT publication WO2005/072748 Priority application(s): WO2005/072748

18 November 2010 Application Accepted

  Published as AU-B-2005209256

17 March 2011 Standard Patent Sealed

16 August 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209257-Vanilloid receptor ligands and their use in treatments of inflammatory and neurotic pain.

2005209254-Ceramic packing element for mass transfer applications